Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate

被引：1
|
作者：
Jacopo Giuliani [1 ]
Andrea Bonetti [1 ]
机构：
[1] Department of Oncology,Mater Salutis Hospital-ASL 21 della Regione Veneto,Legnago (VR),Italy
来源：
Chinese Journal of Cancer Research | 2013年 / 25卷 / 05期
关键词：
GIST; Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate;
D O I：
暂无
中图分类号：
R735 [消化系肿瘤];
学科分类号：
100214 ;
摘要：
Gastrointestinal stromal tumor(GIST)is the most common mesenchymal malignancy of the gastrointestinal tract.GISTs may coexist with different types of cancer,either synchronous or metachronous(1).Most GISTs develop in a sporadic fashion,but familial occurrence,such as neurofibromatosis and Carney-triad,has also been reported(2).The overall frequency of second tumors in different series varied from
引用
收藏
页码：486 / 487
页数：2
相关论文
共 50 条
  • [1] Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate
    Giuliani, Jacopo
    Bonetti, Andrea
    CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (05) : 486 - 487
  • [2] The incidence of second primary malignancies after gastrointestinal stromal tumor before and after the introduction of imatinib mesylate
    Phan, Kim
    Martires, Kathryn
    Kurlander, Dave E.
    Gaddipati, Kishore
    Xavier, Marin
    TRANSLATIONAL CANCER RESEARCH, 2014, 3 (02) : 152 - 159
  • [3] Imaging of Gastrointestinal Stromal Tumors before and after Imatinib Mesylate Therapy
    Shankar, S.
    Dundamadappa, S. K.
    Karam, A. R.
    Stay, R. M.
    van Sonnenberg, E.
    ACTA RADIOLOGICA, 2009, 50 (08) : 837 - 844
  • [4] MDCT appearance of gastrointestinal stromal tumors after therapy with imatinib mesylate
    Warakaulle, DR
    Gleeson, F
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2006, 186 (02) : 510 - 515
  • [5] Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST)
    Fiore, M.
    Palassini, E.
    Fumagalli, E.
    Pilotti, S.
    Tamborini, E.
    Stacchiotti, S.
    Pennacchioli, E.
    Casali, P. G.
    Gronchi, A.
    EJSO, 2009, 35 (07): : 739 - 745
  • [6] Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
    Demetri, GD
    von Mehren, M
    Blanke, CD
    Van den Abbeele, AD
    Eisenberg, B
    Roberts, PJ
    Heinrich, MC
    Tuveson, DA
    Singer, S
    Janicek, M
    Fletcher, JA
    Silverman, SG
    Silberman, SL
    Capdeville, R
    Kiese, B
    Peng, B
    Dimitrijevic, S
    Druker, BJ
    Corless, C
    Fletcher, CDM
    Joensuu, H
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07): : 472 - 480
  • [7] Gastrointestinal stromal tumors and second primary malignancies: a retrospective monocentric analysis
    Comandini, D.
    Grassi, M.
    Prelaj, A.
    Martelli, V
    Damiani, A.
    Damiano, G.
    Rebuzzi, S. Elena
    NEOPLASMA, 2020, 67 (06) : 1416 - 1423
  • [8] Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients
    Tatsuo Kanda
    Toshirou Nishida
    Norihito Wada
    Osamu Kobayashi
    Masakazu Yamamoto
    Akira Sawaki
    Narikazu Boku
    Masato Koseki
    Toshihiko Doi
    Yasushi Toh
    Yoshihiro Kakeji
    Toshiro Sugiyama
    Yoshito Komatsu
    Shojiro Kikuchi
    Kyoji Ogoshi
    Hitoshi Katai
    Kazuhito Miyachi
    Seiichi Hirota
    Atsushi Ohtsu
    International Journal of Clinical Oncology, 2013, 18 : 38 - 45
  • [9] MUTATIONAL ANALYSIS BEFORE AND AFTER NEOADJUVANT IMATINIB MESYLATE FOR LOCALLY ADVANCED GASTROINTESTINAL STROMAL TUMOURS
    Lemke, M.
    Ko, Y. H.
    Law, C.
    Haid, V.
    Rowsell, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 490 - 490
  • [10] The Occurrence of Gastrointestinal Stromal Tumors and Second Malignancies
    Giuliani J.
    Bonetti A.
    Journal of Gastrointestinal Cancer, 2015, 46 (4) : 408 - 412
12345